|
|
Volumn 13, Issue 5 PART II, 1998, Pages 623-643
|
|
Cost-effectiveness analysis of treatments to reduce cholesterol levels, blood pressure and smoking for the prevention of coronary heart disease evaluative study carried out in Spain
a
a
Department of Health
*
(Spain)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
CAPTOPRIL;
COLESTYRAMINE;
FIBRIC ACID DERIVATIVE;
GEMFIBROZIL;
HYDROCHLOROTHIAZIDE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
HYPOCHOLESTEROLEMIC AGENT;
MEVINOLIN;
NIFEDIPINE;
PRAZOSIN;
PROPRANOLOL;
ARTICLE;
BLOOD PRESSURE;
CHOLESTEROL BLOOD LEVEL;
COST EFFECTIVENESS ANALYSIS;
HUMAN;
HYPERCHOLESTEROLEMIA;
ISCHEMIC HEART DISEASE;
PRIORITY JOURNAL;
SMOKING;
SPAIN;
ADULT;
AGED;
ANTICHOLESTEREMIC AGENTS;
ANTIHYPERTENSIVE AGENTS;
CORONARY DISEASE;
COST-BENEFIT ANALYSIS;
FEMALE;
HEALTH RESOURCES;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERCHOLESTEROLEMIA;
HYPERTENSION;
MALE;
MIDDLE AGED;
SMOKING CESSATION;
|
|
EID: 0031924530
PISSN: 11707690
EISSN: None
Source Type: Journal
DOI: 10.2165/00019053-199813050-00014 Document Type: Article |
|
Times cited : (26)
|
|
References (2)
|
